InvestorsHub Logo
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

Re: None

Friday, 04/01/2022 10:28:57 AM

Friday, April 01, 2022 10:28:57 AM

Post# of 565
A quick reading of the Annual Report left me with a recollection of the following paragraph.
" Sales and Marketing
MyMD does not currently have sales and marketing infrastructure to support the launch of its products. MyMD intends to build such capabilities in North America prior to launch of MYMD-1. Outside of North America, MyMD may rely on licensing, co-sale and co-promotion agreements with strategic partners for commercialization of its products."
I had posted previously that I thought their best chance for success was to demonstrate MYMD-1's value through successful Phase 2 studies, then license them to appropriate international pharmaceutical companies in exchange for progress payments and royalties. The quoted paragraph above seems like a good alternative.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMD News